Back to New Hampshire

HB1702 • 2026

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Abortion
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Samuel Farrington (R), Kristine Perez (R), Cindy Bennett (R), Maureen Mooney (R), John Sellers (R), Matt Sabourin dit Choinière (R), Jeanine Notter (R), James Thibault (R), Kevin Avard (R), Mark Pearson (R)
Last action
2026-02-27
Official status
HOUSE
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

What This Bill Does

  • relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-02-27 H

    Committee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102

  2. 2026-02-05 H

    Public Hearing: 02/09/2026 01:00 pm GP 158

  3. 2026-02-05 H

    Executive Session: 02/13/2026 10:00 am GP 158

  4. 2025-12-12 H

    Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 32

Official Summary Text

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Current Bill Text

Read the full stored bill text
HB 1702-FN - AS INTRODUCED

2026 SESSION
26-3147
06/09

HOUSE BILL
1702-FN

AN ACT
relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

SPONSORS: Rep. Farrington, Straf. 8; Rep. Mooney, Hills. 12; Rep. Notter, Hills. 12; Rep. M. Pearson, Rock. 34; Rep. Perez, Rock. 16; Rep. Sellers, Graf. 10; Rep. Thibault, Merr. 25; Rep. Bennett, Rock. 4; Rep. Sabourin dit Choiniere, Rock. 30; Sen. Avard, Dist 12

COMMITTEE: Judiciary

-----------------------------------------------------------------

ANALYSIS

This bill:

I. Defines "chemical" and "medical abortion" drugs.

II. Requires medical facilities and pharmacies that provides chemical abortion drugs to post a standardized notice regarding the potential reversibility of mifepristone.

III. Establishes signage requirements by facility type, imposes a class B felony for intentional noncompliance, and authorizes civil actions for failure to provide the required notice.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in
bold italics.
Matter removed from current law appears [
in brackets and struckthrough.
]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
26-3147
06/09

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty-Six

AN ACT
relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Purpose. The purpose of this act is to inform women seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions.

2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision:
Chemical Abortion
329:54 Definitions. In this subdivision:
I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or chemical for the purposes of inducing an abortion including, but not limited to, mifepristone.
II. "Medical facility" shall have the same meaning as defined in RSA 329:43, VI.
329:55 Notice.
I. Any medical facility or pharmacy in New Hampshire where any chemical abortion drug is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post a conspicuous sign at least 8.5 inches by 11 inches that is clearly visible to patients and customers. Such sign shall be printed with lettering that is legible and at least 3/4 of an inch boldfaced type and shall read:
"NOTICE TO PATIENTS HAVING CHEMICAL ABORTIONS THAT USE MIFEPRISTONE OR OTHER CHEMICAL ABORTION DRUG: Mifepristone, also known as 'RU-486,' alone is not always effective in ending a pregnancy. It may be possible to reverse its intended effect if the second pill or tablet has not been taken or administered. If you change your mind and wish to continue the pregnancy, you can get immediate help by accessing available resources, including Option Line by Heartbeat International at [insert phone number here]."
II. Any private office or freestanding surgical outpatient clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion shall post the sign required under paragraph I in each patient waiting room and patient consultation room used by patients seeking medical abortions.
III. A hospital or other medical care facility or clinic where mifepristone is prescribed, dispensed, or administered for the purposes of inducing a medical abortion that is not a private office or freestanding surgical outpatient clinic shall post the sign required under paragraph I in each patient admission area.
IV. A pharmacy where mifepristone is prescribed, dispensed, or administered for the purpose of inducing a medication abortion shall post the sign required under paragraph I in the area inside the premises where customers are provided prescription medications, and on the exterior of the premises in the area where customers are provided prescription medications via a drive-through window.
329:56 Enforcement.
I. A health care provider or pharmacy that knowingly violates RSA 329:55 shall be guilty of a class B felony.
II. Any woman prescribed, dispensed, or administered a drug intending to induce a chemical abortion without being informed by the notice outlined under RSA 329:55 may, in a civil action, obtain appropriate relief against the party in violation of RSA 329:55. Such relief shall include monetary damages for any psychological or physical injuries, or both, caused by a violation of this subdivision.

3 Effective Date. This act shall take effect 60 days after its passage.

LBA
26-3147
12/3/25

HB 1702-FN- FISCAL NOTE
AS INTRODUCED

AN ACT
relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

FISCAL IMPACT:

Estimated State Impact

FY 2026
FY 2027
FY 2028
FY 2029

Revenue
$0
$0
$0
$0

Revenue Fund
None

Expenditures*
Indeterminable

Funding Source
General Fund

Appropriations*
$0
$0
$0
$0

Funding Source
None

*Expenditure = Cost of bill *Appropriation = Authorized funding to cover cost of bill

Estimated Political Subdivision Impact

FY 2026
FY 2027
FY 2028
FY 2029

County Revenue
$0
$0
$0
$0

County Expenditures
Indeterminable

Local Revenue
$0
$0
$0
$0

Local Expenditures
Indeterminable

METHODOLOGY:
This bill adds, deletes, or modifies a criminal penalty, or changes statute to which there is a penalty for violation. Therefore, this bill may have an impact on the judicial and correctional systems, which could affect prosecution, incarceration, probation, and parole costs, for the state, as well as county and local governments. A summary of such costs can be found at:
https://gencourt.state.nh.us/lba/Budget/Fiscal_Notes/JudicialCorrectionalCosts.pdf

AGENCIES CONTACTED:
Judicial Branch, Judicial Council, Department of Justice, Department of Corrections, New Hampshire Association of Counties, and New Hampshire Municipal Association